Skip to main content

Want a detailed portfolio tracker?

XOMA (XOMA) P/E (2011 - 2026)

XOMA (XOMA) P/E from Mar 31, 2011 to Jun 3, 2026. The TTM XOMA (XOMA) P/E is 14.93. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of XOMA (XOMA)

YearP/EChange
202614.93+46.88%
202510.16-145.11%
2024-22.53+183.68%
2023-7.94-171.81%
202211.06-26.15%
202114.98-62.23%
202039.65-125.48%
2019-155.59+1846.32%
2018-7.99-77.56%
2017-35.62+1352.59%
2016-2.45-67.14%
2015-7.46-26.76%
2014-10.19+100.43%
2013-5.08+122.15%
2012-2.29+45.97%
2011-1.57N/A

Comparison XOMA (XOMA) P/E with competitors

XOMA (XOMA) P/E is 14.93.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.10-99.32%
ENLVEnlivex Therapeutics Ltd0.15-98.99%
FGENFibroGen Inc0.24-98.39%
TRAWTraws Pharma Inc0.47-96.83%
FBIOFortress Biotech Inc0.71-95.27%
CHRSCoherus Biosciences Inc0.98-93.45%
ORMPOramed Pharmaceuticals Inc1.47-90.13%
AGENAgenus Inc2.05-86.28%
VIVSVivoSim Labs Inc2.54-83.02%
INVAInnoviva Inc3.19-78.65%
CRMDCorMedix Inc3.65-75.58%
ABEOAbeona Therapeutics Inc4.20-71.84%
VXRTVaxart Inc4.26-71.46%
CVACCureVac N.V.4.45-70.23%
SRPTSarepta Therapeutics Inc4.62-69.03%
GLPGGalapagos NV4.86-67.46%
RIGLRigel Pharmaceuticals4.92-67.05%
ZVRAZevra Therapeutics Inc4.97-66.69%
ABUSArbutus Biopharma Corp5.69-61.87%
CGENCompugen Ltd7.38-50.55%
AUPHAurinia Pharmaceuticals Inc9.25-38.04%
ACADAcadia Pharmaceuticals Inc9.59-35.78%
OMEROmeros Corporation9.88-33.81%
PLXProtalix BioTherapeutics Inc9.91-33.63%
SPROSpero Therapeutics Inc10.73-28.10%
ADMAAdma Biologics Inc11.33-24.11%
SVASinovac Biotech Ltd11.44-23.41%
TBPHTheravance Biopharma Inc11.78-21.13%
HRMYHarmony Biosciences Holdings Inc12.18-18.42%
TGTXTG Therapeutics Inc13.18-11.73%
INCYIncyte Corp13.38-10.37%
SABSSAB Biotherapeutics Inc14.06-5.85%
REGNRegeneron Pharmaceuticals Inc14.98+0.33%
PBYIPuma Biotechnology Inc15.05+0.80%
EXELExelixis Inc15.79+5.79%
NAGENiagen Bioscience Inc16.35+9.54%
CPRXCatalyst Pharmaceuticals Inc17.34+16.17%
MDXGMimedx Group Inc17.38+16.37%
ARGXArgen X SE23.07+54.52%
HALOHalozyme Therapeutics Inc23.20+55.39%
XOMAOXOMA Corp25.34+69.75%
VRTXVertex Pharmaceuticals Inc25.66+71.83%
XOMAPXOMA Corp25.67+71.93%
CTMXCytomX Therapeutics Inc25.70+72.11%
ASNDAscendis Pharma A/S26.35+76.51%
RPRXRoyalty Pharma plc - Class A27.50+84.15%
SLNOSoleno Therapeutics Inc29.02+94.33%
LGNDLigand Pharmaceuticals Inc - Class B30.19+102.17%
BMRNBiomarin Pharmaceutical Inc37.51+151.21%
APLSApellis Pharmaceuticals Inc39.02+161.35%
KRYSKrystal Biotech Inc39.70+165.88%
GMABGenmab40.20+169.26%
ONCBeiGene Ltd67.03+348.91%
TECHBio-Techne Corp68.59+359.42%
VCELVericel Corp80.63+440.02%
PHARPharming Group N.V.87.74+487.64%
ALNYAlnylam Pharmaceuticals Inc124.93+736.75%
TLXTelix Pharmaceuticals Ltd139.89+836.92%
CORTCorcept Therapeutics Inc158.39+960.82%